JF
IMNM icon

Jump Financial’s Immunome IMNM Stock Holding History

Jump Financial’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Sell
9,500
-14,077
-60% -$301K ﹤0.01% 1852
2026
Q1 		$516K Buy
+23,577
New +$525K 0.01% 1227
2024
Q3 		– Sell
-134,300
Closed -$1.63M – 1861
2024
Q2 		$1.63M Buy
+134,300
New +$2.1M 0.03% 636
2024
Q1 		– Sell
-16,100
Closed -$172K – 2069
2023
Q4 		$172K Buy
+16,100
New +$134K 0.01% 1601

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Jump Financial's IMNM Position: Q2 2026 in Review

Jump Financial reduced its Immunome (IMNM) stake by 60% in Q2 2026, selling an estimated $301K and leaving 9,500 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Jump Financial first reported a position in IMNM in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.63M in Q2 2024. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Jump Financial held 9,500 shares of Immunome worth $201K as of Q2 2026.
  • Jump Financial sold 14,077 Immunome shares in Q2 2026, an estimated $301K.
  • Immunome made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1852 holding.
  • Jump Financial first reported a position in Immunome in Q4 2023 and has held it in 4 quarters since.
  • Jump Financial's Immunome position peaked at $1.63M in Q2 2024.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.